Year: 2021
Type: review
Abstract: As part of the centennial celebration of insulin's discovery, this review summarizes the current understanding of the genetics, pathogenesis, treatment, and outcomes in type 1 diabetes (T1D). T1D results from an autoimmune response that leads to destruction of the β cells in the pancreatic islet and requires lifelong insulin therapy. While much has been learned about T1D, it is now clear that there is considerable heterogeneity in T1D with regard to genetics, pathology, response to immune-based therapies, clinical course, and susceptibility to diabetes-related complications. This Review highlights knowledge gaps and opportunities to improve the understanding of T1D pathogenesis and outlines emerging therapies to treat or prevent T1D and reduce the burden of T1D.
DOI: 10.1172/jci142242
Author: Alvin C. Powers
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
Awards: Molecular Mechanisms of Postnatal Islet alpha-cell Proliferation, Human Pancreas Analysis Program-T2D, Therapeutic targeting of human islets with recombinant regulatory T cells, Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas, G6845279160, Integrated Program for Human Pancreas Procurement and Analysis, Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus, High-resolution analysis of juvenile human pancreas maturation, Vanderbilt Diabetes Research Center
OpenAlex ID: W3138583964
